Novo Nordisk Warns of Stolen Medications

Novo Nordisk has issued a statement cautioning against the purchase of their medications from unauthorized sources after a recent theft of their products during transportation. The stolen products, including weight-loss drug semaglutide and diabetes treatments insulin Aspart and Degludec, are required to be stored at a specific temperature to maintain their integrity and effectiveness. Novo Nordisk has assured that they are cooperating with the investigation and have taken measures to strengthen their supply chain to prevent similar incidents in the future.

Key Takeaways:

• Novo Nordisk has reported the theft of a minor quantity of their medications during transportation by their distribution partners.
• The stolen products include weight-loss drug semaglutide and diabetes treatments insulin Aspart and Degludec.
• Novo Nordisk has assured that patient safety is their top priority and has taken additional measures to strengthen their supply chain.
• The Central Drugs Standard Control Organization (CDSCO) has issued an alert to healthcare professionals to be careful in prescribing Novo Nordisk products.
• The CDSCO has directed patients and consumers to procure their products from authorized sources only with due invoices.
• Novo Nordisk's products require to be stored at a specific temperature to maintain their integrity and effectiveness.
• The company has informed about a theft of its products during transit from its Bhiwandi Hub to milk route (Nagpur, Raipur, Cuttack, and Kolkata).

Statistics:

• Minor quantity of Novo Nordisk medications stolen during transportation.
• Products stolen include weight-loss drug semaglutide and diabetes treatments insulin Aspart and Degludec.
• Novo Nordisk products require to be stored at a temperature range of (2°C to 8°C) to maintain their integrity and effectiveness.
• Central Drugs Standard Control Organization (CDSCO) has issued an alert to healthcare professionals on the theft of Novo Nordisk products.

Sources:

• ET News
• Novo Nordisk Statement
• Central Drugs Standard Control Organization (CDSCO) Alert